Mendelian randomization implicates circulating plasma proteins in gout risk and identifies candidate therapeutic targets

Key Points

• This research aims to identify plasma proteins associated with increased risk of gout and assess their potential for therapeutic targeting.
• Utilized Mendelian randomization to explore associations between plasma proteins and gout risk.
• Nominated five circulating proteins as candidates for further investigation.
• Employed a cross-dataset approach to examine potential heterogeneity.
• Five circulating proteins were identified as potential candidates for gout risk.
• Findings are preliminary and require functional validation and independent replication.
• The study highlights the need to clarify mechanisms and confirm targetability of the identified proteins.